Tuberculosis vaccine candidates based on mycobacterial cell envelope components
- Autores
- Sarmiento, M.E.; Alvarez, N.; Chin, K.L.; Bigi, Fabiana; Tirado, Y.; García, M.A.; Anis, F.Z.; Norazmi, M.N.; Acosta, A.
- Año de publicación
- 2019
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Even after decades searching for a new and more effective vaccine against tuberculosis, the scientific community is still pursuing this goal due to the complexity of its causative agent, Mycobacterium tuberculosis (Mtb). Mtb is a microorganism with a robust variety of survival mechanisms that allow it to remain in the host for years. The structure and nature of the Mtb envelope play a leading role in its resistance and survival. Mtb has a perfect machinery that allows it to modulate the immune response in its favor and to adapt to the host's environmental conditions in order to remain alive until the moment to reactivate its normal growing state. Mtb cell envelope protein, carbohydrate and lipid components have been the subject of interest for developing new vaccines because most of them are responsible for the pathogenicity and virulence of the bacteria. Many indirect evidences, mainly derived from the use of monoclonal antibodies, support the potential protective role of Mtb envelope components. Subunit and DNA vaccines, lipid extracts, liposomes and membrane vesicle formulations are some examples of technologies used, with encouraging results, to evaluate the potential of these antigens in the protective response against Mtb.
Fil: Sarmiento, M.E.. Universiti Sains Malaysia; Malasia
Fil: Alvarez, N.. Public Health Research Institute; Estados Unidos
Fil: Chin, K.L.. Universiti Sains Malaysia; Malasia
Fil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; Argentina
Fil: Tirado, Y.. No especifíca;
Fil: García, M.A.. No especifíca;
Fil: Anis, F.Z.. Universiti Sains Malaysia; Malasia
Fil: Norazmi, M.N.. Universiti Sains Malaysia; Malasia
Fil: Acosta, A.. Universiti Sains Malaysia; Malasia - Materia
-
CELL WALL
MEMBRANE
MYCOBACTERIUM TUBERCULOSIS
VACCINES
VESICLES - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/149159
Ver los metadatos del registro completo
id |
CONICETDig_4b81768e3a6d9e462ac86bbcda962317 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/149159 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Tuberculosis vaccine candidates based on mycobacterial cell envelope componentsSarmiento, M.E.Alvarez, N.Chin, K.L.Bigi, FabianaTirado, Y.García, M.A.Anis, F.Z.Norazmi, M.N.Acosta, A.CELL WALLMEMBRANEMYCOBACTERIUM TUBERCULOSISVACCINESVESICLEShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Even after decades searching for a new and more effective vaccine against tuberculosis, the scientific community is still pursuing this goal due to the complexity of its causative agent, Mycobacterium tuberculosis (Mtb). Mtb is a microorganism with a robust variety of survival mechanisms that allow it to remain in the host for years. The structure and nature of the Mtb envelope play a leading role in its resistance and survival. Mtb has a perfect machinery that allows it to modulate the immune response in its favor and to adapt to the host's environmental conditions in order to remain alive until the moment to reactivate its normal growing state. Mtb cell envelope protein, carbohydrate and lipid components have been the subject of interest for developing new vaccines because most of them are responsible for the pathogenicity and virulence of the bacteria. Many indirect evidences, mainly derived from the use of monoclonal antibodies, support the potential protective role of Mtb envelope components. Subunit and DNA vaccines, lipid extracts, liposomes and membrane vesicle formulations are some examples of technologies used, with encouraging results, to evaluate the potential of these antigens in the protective response against Mtb.Fil: Sarmiento, M.E.. Universiti Sains Malaysia; MalasiaFil: Alvarez, N.. Public Health Research Institute; Estados UnidosFil: Chin, K.L.. Universiti Sains Malaysia; MalasiaFil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; ArgentinaFil: Tirado, Y.. No especifíca;Fil: García, M.A.. No especifíca;Fil: Anis, F.Z.. Universiti Sains Malaysia; MalasiaFil: Norazmi, M.N.. Universiti Sains Malaysia; MalasiaFil: Acosta, A.. Universiti Sains Malaysia; MalasiaChurchill Livingstone2019-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/149159Sarmiento, M.E.; Alvarez, N.; Chin, K.L.; Bigi, Fabiana; Tirado, Y.; et al.; Tuberculosis vaccine candidates based on mycobacterial cell envelope components; Churchill Livingstone; Tuberculosis (Edinb); 115; 3-2019; 26-411472-9792CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S1472979218304943info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tube.2019.01.003info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T09:50:03Zoai:ri.conicet.gov.ar:11336/149159instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 09:50:04.15CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
title |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
spellingShingle |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components Sarmiento, M.E. CELL WALL MEMBRANE MYCOBACTERIUM TUBERCULOSIS VACCINES VESICLES |
title_short |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
title_full |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
title_fullStr |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
title_full_unstemmed |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
title_sort |
Tuberculosis vaccine candidates based on mycobacterial cell envelope components |
dc.creator.none.fl_str_mv |
Sarmiento, M.E. Alvarez, N. Chin, K.L. Bigi, Fabiana Tirado, Y. García, M.A. Anis, F.Z. Norazmi, M.N. Acosta, A. |
author |
Sarmiento, M.E. |
author_facet |
Sarmiento, M.E. Alvarez, N. Chin, K.L. Bigi, Fabiana Tirado, Y. García, M.A. Anis, F.Z. Norazmi, M.N. Acosta, A. |
author_role |
author |
author2 |
Alvarez, N. Chin, K.L. Bigi, Fabiana Tirado, Y. García, M.A. Anis, F.Z. Norazmi, M.N. Acosta, A. |
author2_role |
author author author author author author author author |
dc.subject.none.fl_str_mv |
CELL WALL MEMBRANE MYCOBACTERIUM TUBERCULOSIS VACCINES VESICLES |
topic |
CELL WALL MEMBRANE MYCOBACTERIUM TUBERCULOSIS VACCINES VESICLES |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Even after decades searching for a new and more effective vaccine against tuberculosis, the scientific community is still pursuing this goal due to the complexity of its causative agent, Mycobacterium tuberculosis (Mtb). Mtb is a microorganism with a robust variety of survival mechanisms that allow it to remain in the host for years. The structure and nature of the Mtb envelope play a leading role in its resistance and survival. Mtb has a perfect machinery that allows it to modulate the immune response in its favor and to adapt to the host's environmental conditions in order to remain alive until the moment to reactivate its normal growing state. Mtb cell envelope protein, carbohydrate and lipid components have been the subject of interest for developing new vaccines because most of them are responsible for the pathogenicity and virulence of the bacteria. Many indirect evidences, mainly derived from the use of monoclonal antibodies, support the potential protective role of Mtb envelope components. Subunit and DNA vaccines, lipid extracts, liposomes and membrane vesicle formulations are some examples of technologies used, with encouraging results, to evaluate the potential of these antigens in the protective response against Mtb. Fil: Sarmiento, M.E.. Universiti Sains Malaysia; Malasia Fil: Alvarez, N.. Public Health Research Institute; Estados Unidos Fil: Chin, K.L.. Universiti Sains Malaysia; Malasia Fil: Bigi, Fabiana. Instituto Nacional de Tecnología Agropecuaria. Centro de Investigación en Ciencias Veterinarias y Agronómicas. Instituto de Agrobiotecnología y Biología Molecular. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Agrobiotecnología y Biología Molecular; Argentina Fil: Tirado, Y.. No especifíca; Fil: García, M.A.. No especifíca; Fil: Anis, F.Z.. Universiti Sains Malaysia; Malasia Fil: Norazmi, M.N.. Universiti Sains Malaysia; Malasia Fil: Acosta, A.. Universiti Sains Malaysia; Malasia |
description |
Even after decades searching for a new and more effective vaccine against tuberculosis, the scientific community is still pursuing this goal due to the complexity of its causative agent, Mycobacterium tuberculosis (Mtb). Mtb is a microorganism with a robust variety of survival mechanisms that allow it to remain in the host for years. The structure and nature of the Mtb envelope play a leading role in its resistance and survival. Mtb has a perfect machinery that allows it to modulate the immune response in its favor and to adapt to the host's environmental conditions in order to remain alive until the moment to reactivate its normal growing state. Mtb cell envelope protein, carbohydrate and lipid components have been the subject of interest for developing new vaccines because most of them are responsible for the pathogenicity and virulence of the bacteria. Many indirect evidences, mainly derived from the use of monoclonal antibodies, support the potential protective role of Mtb envelope components. Subunit and DNA vaccines, lipid extracts, liposomes and membrane vesicle formulations are some examples of technologies used, with encouraging results, to evaluate the potential of these antigens in the protective response against Mtb. |
publishDate |
2019 |
dc.date.none.fl_str_mv |
2019-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/149159 Sarmiento, M.E.; Alvarez, N.; Chin, K.L.; Bigi, Fabiana; Tirado, Y.; et al.; Tuberculosis vaccine candidates based on mycobacterial cell envelope components; Churchill Livingstone; Tuberculosis (Edinb); 115; 3-2019; 26-41 1472-9792 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/149159 |
identifier_str_mv |
Sarmiento, M.E.; Alvarez, N.; Chin, K.L.; Bigi, Fabiana; Tirado, Y.; et al.; Tuberculosis vaccine candidates based on mycobacterial cell envelope components; Churchill Livingstone; Tuberculosis (Edinb); 115; 3-2019; 26-41 1472-9792 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/abs/pii/S1472979218304943 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.tube.2019.01.003 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Churchill Livingstone |
publisher.none.fl_str_mv |
Churchill Livingstone |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1844613545482780672 |
score |
13.070432 |